Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations.
primary studies published RCT
Details- 2022
- Gold LS
Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation.
primary studies published RCT
Details- 2022
- Roder L
Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis related diabetes -PIM study: a multicenter phase 1-2 trial.
primary studies published RCT
Details- 2022
- Rakotoarisoa L
The Effect of Control IQ Hybrid Closed Loop Technology on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes.
primary studies published RCT
Details- 2022
- Scully KJ
The Short Term Influence of Chest Physiotherapy on Lung Function Parameters in Children With Cystic Fibrosis and Primary Ciliary Dyskinesia.
primary studies published RCT
Details- 2022
- Vandervoort B
The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis.
primary studies published RCT
Details- 2022
- Tosco A
Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation.
primary studies published RCT
Details- 2021
- Taylor-Cousar JL
Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion.
primary studies published RCT
Details- 2021
- Colombo C
Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.
primary studies published RCT
Details- 2021
- Nichols DP
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart.
primary studies published RCT
Details- 2021
- Akkerman-Nijland AM